Frontier Small Cap Growth Fund  (MSSCX)

Fund Overview

Fund Overview

Share Class

I

NAV | as of 10/28/2020

$9.11
-$0.29 (-3.09%)

Morningstar | Style Box

V B G L M S

Overall Morningstar Rating


Rated against 579 Small Growth funds as of 09/30/2020

View Morningstar Details

Growth of $10,000 (Hypothetical)

Since Inception 09/24/1997 to 09/30/2020 = $64,591.29

  • 3YR
  • 5YR
  • 10YR
  • INCEP.
INCEP.
  • 3YR
  • 5YR
  • 10YR
  • INCEP.

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown.

Objective

Seeks long-term capital appreciation by investing in a portfolio of small cap stocks.

Why Consider

  • May be appropriate for investors looking to gain exposure to small cap stocks
  • Manager brings a long history of disciplined investing in small and mid cap stocks, emphasizing fundamental research and bottom-up stock selection
  • Targets companies with solid business models with strong earnings power while selling at reasonable valuations
James A. Colgan

James A. Colgan

Senior Vice President

See Our Approach Read Bio
G. Michael Novak, Jr.

G. Michael Novak, Jr.

Senior Vice President

See Our Approach Read Bio

Performance

Performance

Read Important Investment Disclosures

Returns

 

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown. Returns for periods less than one year are not annualized.

Expense Ratios

  • Gross Expense Ratio: 1.58%
  • Net Expense Ratio: 0.96%
  • Expense Cap Expiration Date: 03/01/2021

Distributions & Pricing


    • Calendar Year Distributions

    • Ex-Date Total Distribution Income Short-term Cap Gains Long-term Cap Gains
      Dec 16, 2019 $0.723300 $0.723300
      Dec 27, 2018 $4.050300 $1.955200 $2.095100
      Dec 27, 2017 $2.996200 $0.709000 $2.287200
      Dec 27, 2016 $0.048300 $0.048300
      Dec 28, 2015 $3.043900 $0.056500 $2.987400
      Dec 26, 2014 $11.760100 $2.448900 $9.311200
      Dec 26, 2013 $3.013600 $1.215500 $1.798100
      Dec 15, 2000 $1.684420 $0.074080 $1.610340
      Oct 25, 2000 $1.280000 $1.280000
      Dec 15, 1999 $0.105800 $0.105800
      Oct 26, 1999 $0.600000 $0.600000
      Dec 15, 1997 $0.002760 $0.002670 $0.000090
      Oct 31, 1997 $0.024000 $0.015000 $0.009000

Risk & Return Stats

As of: 09/30/2020

View All Characteristics & Stats

Portfolio & Holdings

Portfolio & Holdings

Top Holdings (Equity)

As of: 09/30/2020

Insulet Corp 3.63%
Caesars Entertainment Inc 3.43%
Karyopharm Therapeutics Inc 3.38%
Natera Inc 3.35%
Horizon Therapeutics Plc 3.10%
Guardant Health Inc 2.88%
Century Communities Inc 2.78%
Adaptive Biotechnologies Corp 2.77%
Quanterix Corp 2.48%
Silk Road Medical Inc 2.17%
% in Top 10 Holdings 29.97%
View Holding Details Read Important Investment Disclosures

Sector Allocation (Equity)

As of: 09/30/2020

Investment Approach

Investment Approach

Frontier Small Cap Growth Fund

The Fund invests primarily in common stocks of small U.S. companies whose market capitalization at the time of purchase is within the range of the Russell 2000® Index, the S&P Small Cap 600 Index, or the Dow Jones U.S. Small Cap Total Stock Market Index.

Frontier utilizes and draws support from its entire team of investment professionals to identify opportunities and conduct fundamental research. Through fundamental bottom-up research, Frontier seeks long-term capital appreciation by investing in small cap companies that it believes have above-average earnings growth potential and are available at reasonable valuations.


Crises, Manias and Irrational Exuberance—Financial Bubbles Throughout History: A Cautionary Tale

 
What are the human behaviors that have driven financial bubbles to develop? Learning from history—and understanding how these bubbles form and burst—can help investors take important steps to prepare.
Read Full Perspective

  Read Full Perspective

About

About Frontier Capital Management

Background

Frontier Capital Management Company, LLC specializes in growth and value equity investments on behalf of institutional and individual clients.

Learn More

Founded

1980


Headquarters

Boston


Affiliate Since

2000

Funds to Consider

HLMNX

Harding Loevner International Equity Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based outside the United States.


Overall Morningstar Rating

Rated against 420 Foreign Large Growth funds as of 09/30/2020
★★★

HLMNX
MSCI ACWI ex USA Index

Quarterly performance (%) data as of 09/30/2020

Fund Detail Read Important Investment Disclosures

GWMIX

GW&K Municipal Bond Fund

The Fund seeks to provide current income, exempt from federal income tax, and capital preservation by primarily investing in a portfolio of high-quality municipal bonds.


Overall Morningstar Rating

Rated against 240 Muni National Interm funds as of 09/30/2020
★★★

GWMIX
Bloomberg Barclays 10-Year Municipal Bond Index

Quarterly performance (%) data as of 09/30/2020

Fund Detail Read Important Investment Disclosures

TYWVX

GW&K Emerging Wealth Equity Fund

Seeks to provide long-term capital appreciation by investing in emerging market companies and developed market companies that have emerging markets revenue exposure.


Overall Morningstar Rating

Rated against 695 Diversified Emerging Mkts funds as of 09/30/2020
★★★★

TYWVX
MSCI Emerging Markets Index

Quarterly performance (%) data as of 09/30/2020

Fund Detail Read Important Investment Disclosures

Discover how AMG Funds brings more than 70 products from over 25 independent boutiques together under one flag.

Learn More About AMG Funds
  Back To Top